Silver Book Fact

Spending $1,000 per year on anticoagulants can save $100,000 in hospital costs for care of a person disabled by a stroke.

Giorgianni S, Grana J, Scipioni L. Global Impact of Innovations on Chronic Disease in the Genomics Era. The Pfizer Journal. 01-Nov-2001; 11

Reference

Title
Global Impact of Innovations on Chronic Disease in the Genomics Era
Publication
The Pfizer Journal
Publisher
Pfizer Inc
Publication Date
01-Nov-2001
Authors
Giorgianni S, Grana J, Scipioni L

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Cost-savings associated with optimal anticoagulation in AFib patients
    If half of all atrial fibrillation patients receiving suboptimal or no anticoagulation instead received optimal anticoagulation, 28,000 strokes could be prevented each year at a savings of around $2.5 billion in direct…  
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • Aspirin as stroke prevention
    Aspirin reduces stroke rate by 20% in patients with myocardial infarction.  
  • Heart Failure Disease Management (DM) Program Reduces Hospitalizations and Overall Costs  
  • Increased use of non-acute medications in primary and secondary prevention explains about 1/3 of the total reduction in cardiovascular disease mortality since 1950.